SCHEMBL29515251

SCHEMBL29515251

Cc1c(OC[C@H](N)CC(C)(C)C)nc(NS(=O)(=O)c2cccc(C(=O)O)c2)nc1-c1ccccc1C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.38
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PTK2B Q14289 1/20 0.35
▸ ACLY P53396 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ SENP8 Q96LD8 1/20 0.34
▸ SENP7 Q9BQF6 1/20 0.34
▸ SENP6 Q9GZR1 1/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24331171 1.00 AKR1C3 (0.38) AKR1C3KMT2AMEN1POLBMAPT
SCHEMBL24331952 0.91 ALDH1A1 (0.37) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL29515226 0.91 ALDH1A1 (0.37) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL29515013 0.87 ALDH1A1 (0.40) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL24331066 0.87 ALDH1A1 (0.40) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL24331172 0.85 LDHA (0.31) —
SCHEMBL29515185 0.84 ALDH1A1 (0.36) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL24331145 0.84 ALDH1A1 (0.36) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL30588747 0.84 CASP3 (0.37) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL26126196 0.84 CASP3 (0.37) AKR1C3KMT2AMEN1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225761-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076620-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback